{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:03:36Z","timestamp":1791169416562,"version":"4.1.0"},"reference-count":52,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/ijo.2012.1729","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T09:41:39Z","timestamp":1354786899000},"page":"419-428","source":"Crossref","is-referenced-by-count":7,"title":["PECAM-1 is involved in BCR\/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells"],"prefix":"10.3892","volume":"42","author":[{"given":"NAN","family":"WU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TETSUYA","family":"KUROSU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GAKU","family":"OSHIKAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOSHIKAGE","family":"NAGAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OSAMU","family":"MIURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,12,6]]},"reference":[{"key":"key20180107181118_b1-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI119129","article-title":"The biology of PECAM-1","volume":"99","author":"Newman","year":"1997","journal-title":"J Clin Invest"},{"key":"key20180107181118_b2-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lfs.2010.06.001","article-title":"PECAM-1: conflicts of interest in inflammation","volume":"87","author":"Privratsky","year":"2010","journal-title":"Life Sci"},{"key":"key20180107181118_b3-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0955-0674(03)00100-5","article-title":"PECAM-1: old friend, new partners","volume":"15","author":"Ilan","year":"2003","journal-title":"Curr Opin Cell Biol"},{"key":"key20180107181118_b4-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-5793(03)00224-2","article-title":"The unfolding tale of PECAM-1","volume":"540","author":"Jackson","year":"2003","journal-title":"FEBS Lett"},{"key":"key20180107181118_b5-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1182\/blood-2006-10-050740","article-title":"A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice","volume":"109","author":"Dhanjal","year":"2007","journal-title":"Blood"},{"key":"key20180107181118_b6-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"e2338","DOI":"10.1371\/journal.pone.0002338","article-title":"A novel role for PECAM-1 (CD31) in regulating haematopoietic progenitor cell compartmentalization between the peripheral blood and bone marrow","volume":"3","author":"Ross","year":"2008","journal-title":"PLoS One"},{"key":"key20180107181118_b7-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/bj20031160","article-title":"Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2)","volume":"376","author":"Wheadon","year":"2003","journal-title":"Biochem J"},{"key":"key20180107181118_b8-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.1158\/0008-5472.CAN-07-0402","article-title":"The role of platelet\/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells","volume":"67","author":"Gallay","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107181118_b9-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.exphem.2010.05.001","article-title":"VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers","volume":"38","author":"Akers","year":"2010","journal-title":"Exp Hematol"},{"key":"key20180107181118_b10-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/cncr.11264","article-title":"Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia","volume":"97","author":"Ibrahim","year":"2003","journal-title":"Cancer"},{"key":"key20180107181118_b11-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood-2008-03-144576","article-title":"No convincing evidence for a role of CD31-38 interactions in the pathogenesis of chronic lymphocytic leukemia","volume":"112","author":"Tonino","year":"2008","journal-title":"Blood"},{"key":"key20180107181118_b12-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia - advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N Engl J Med"},{"key":"key20180107181118_b13-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","article-title":"The BCR-ABL story: bench to bedside and back","volume":"22","author":"Wong","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"key20180107181118_b14-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2141.2009.07666.x","article-title":"Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia","volume":"145","author":"Gruber","year":"2009","journal-title":"Br J Haematol"},{"key":"key20180107181118_b15-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbrc.2004.05.113","article-title":"The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR\/ABL fusion kinase","volume":"319","author":"Yamamoto","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107181118_b16-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1038\/sj.onc.1210117","article-title":"Rottlerin synergistically enhances imatinib-induced apoptosis of BCR\/ABL-expressing cells through its mitochondrial uncoupling effect independent of protein kinase C-delta","volume":"26","author":"Kurosu","year":"2007","journal-title":"Oncogene"},{"key":"key20180107181118_b17-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1158\/0008-5472.CAN-08-2978","article-title":"Sorafenib induces apoptosis specifically in cells expressing BCR\/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway","volume":"69","author":"Kurosu","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107181118_b18-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1128\/MCB.02202-05","article-title":"Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib","volume":"26","author":"Griswold","year":"2006","journal-title":"Mol Cell Biol"},{"key":"key20180107181118_b19-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"19466","DOI":"10.1073\/pnas.0609239103","article-title":"Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants","volume":"103","author":"Skaggs","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107181118_b20-ijo-42-02-0419","first-page":"3589","article-title":"Activation of Src kinases p53\/56lyn and p59hck by p210bcr\/abl in myeloid cells","volume":"56","author":"Danhauser-Riedl","year":"1996","journal-title":"Cancer Res"},{"key":"key20180107181118_b21-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jnci\/djn188","article-title":"Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase","volume":"100","author":"Wu","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"key20180107181118_b22-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd2324","article-title":"Flying under the radar: the new wave of BCR-ABL inhibitors","volume":"6","author":"Quintas-Cardama","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107181118_b23-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1182\/blood.V91.10.3927.3927_3927_3934","article-title":"Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR\/ABL expression","volume":"91","author":"Klucher","year":"1998","journal-title":"Blood"},{"key":"key20180107181118_b24-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0145-2126(98)00172-6","article-title":"Establishment of a double Philadelphia chromosome-positive acute lymphoblastic leukemia-derived cell line, TMD5: effects of cytokines and differentiation inducers on growth of the cells","volume":"23","author":"Tohda","year":"1999","journal-title":"Leuk Res"},{"key":"key20180107181118_b25-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","article-title":"Plat-E: an efficient and stable system for transient packaging of retroviruses","volume":"7","author":"Morita","year":"2000","journal-title":"Gene Ther"},{"key":"key20180107181118_b26-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/MCB.7.1.379","article-title":"Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system","volume":"7","author":"DuBridge","year":"1987","journal-title":"Mol Cell Biol"},{"key":"key20180107181118_b27-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.bbrc.2004.11.086","article-title":"BCR\/ABL activates Rap1 and B-Raf to stimulate the MEK\/Erk signaling pathway in hematopoietic cells","volume":"326","author":"Mizuchi","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107181118_b28-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1182\/blood.V91.10.3734","article-title":"Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway","volume":"91","author":"Chin","year":"1998","journal-title":"Blood"},{"key":"key20180107181118_b29-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0301-472X(03)00260-1","article-title":"Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics","volume":"31","author":"Kitamura","year":"2003","journal-title":"Exp Hematol"},{"key":"key20180107181118_b30-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"24868","DOI":"10.1074\/jbc.272.40.24868","article-title":"Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet\/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2","volume":"272","author":"Jackson","year":"1997","journal-title":"J Biol Chem"},{"key":"key20180107181118_b31-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood.V97.8.2351","article-title":"Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck)","volume":"97","author":"Newman","year":"2001","journal-title":"Blood"},{"key":"key20180107181118_b32-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"29374","DOI":"10.1074\/jbc.M313955200","article-title":"The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling","volume":"279","author":"Kolli","year":"2004","journal-title":"J Biol Chem"},{"key":"key20180107181118_b33-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"30263","DOI":"10.1074\/jbc.M111.232348","article-title":"c-Cbl and Cbl-b ligases mediate 17-allylaminodemethoxygeldanamycin-induced degradation of autophosphorylated Flt3 kinase with internal tandem duplication through the ubiquitin proteasome pathway","volume":"286","author":"Oshikawa","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180107181118_b34-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/MCB.13.3.1788","article-title":"Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors","volume":"13","author":"Miura","year":"1993","journal-title":"Mol Cell Biol"},{"key":"key20180107181118_b35-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"10453","DOI":"10.1074\/jbc.M004627200","article-title":"Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta1 integrin-mediated hematopoietic cell adhesion","volume":"276","author":"Arai","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107181118_b36-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1038\/sj.onc.1209459","article-title":"BCR\/ABL and IL-3 activate Rap1 to stimulate the B-Raf\/MEK\/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion","volume":"25","author":"Jin","year":"2006","journal-title":"Oncogene"},{"key":"key20180107181118_b37-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/01.ATV.0000071347.69358.D9","article-title":"Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology","volume":"23","author":"Newman","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180107181118_b38-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1073\/pnas.94.5.1680","article-title":"Development of \u2018substrate-trapping\u2019 mutants to identify physiological substrates of protein tyrosine phosphatases","volume":"94","author":"Flint","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107181118_b39-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1083\/jcb.114.5.1059","article-title":"Molecular and cellular properties of PECAM-1 (endoCAM\/CD31): a novel vascular cell-cell adhesion molecule","volume":"114","author":"Albelda","year":"1991","journal-title":"J Cell Biol"},{"key":"key20180107181118_b40-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.4161\/cbt.5.12.3467","article-title":"The cell-adhesion and signaling molecule PECAM-1 is a molecular mediator of resistance to genotoxic chemotherapy","volume":"5","author":"Bergom","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"key20180107181118_b41-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1242\/jcs.112.12.1989","article-title":"Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration","volume":"112","author":"Bird","year":"1999","journal-title":"J Cell Sci"},{"key":"key20180107181118_b42-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood-2002-03-0768","article-title":"Transendothelial migration leads to protection from starvation-induced apoptosis in CD34+CD14+ circulating precursors: evidence for PECAM-1 involvement through Akt\/PKB activation","volume":"101","author":"Ferrero","year":"2003","journal-title":"Blood"},{"key":"key20180107181118_b43-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1182\/blood-2003-01-0003","article-title":"PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis","volume":"102","author":"Gao","year":"2003","journal-title":"Blood"},{"key":"key20180107181118_b44-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/blood-2004-02-0452","article-title":"Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K\/Akt and regulation of Bcl-2 family members","volume":"105","author":"Limaye","year":"2005","journal-title":"Blood"},{"key":"key20180107181118_b45-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10555-008-9126-y","article-title":"The tyrosine phosphatase Shp2 (PTPN11) in cancer","volume":"27","author":"Chan","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107181118_b46-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/blood-2005-08-3087","article-title":"Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)","volume":"107","author":"Scherr","year":"2006","journal-title":"Blood"},{"key":"key20180107181118_b47-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2006-04-019141","article-title":"SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl","volume":"109","author":"Chen","year":"2007","journal-title":"Blood"},{"key":"key20180107181118_b48-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2353\/ajpath.2006.051112","article-title":"PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation","volume":"169","author":"Biswas","year":"2006","journal-title":"Am J Pathol"},{"key":"key20180107181118_b49-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.emboj.7601485","article-title":"Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation","volume":"26","author":"Coluccia","year":"2007","journal-title":"EMBO J"},{"key":"key20180107181118_b50-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","article-title":"beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia","volume":"23","author":"Hu","year":"2009","journal-title":"Leukemia"},{"key":"key20180107181118_b51-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/14653240701508437","article-title":"Activated beta-catenin induces myogenesis and inhibits adipogenesis in BM-derived mesenchymal stromal cells","volume":"9","author":"Shang","year":"2007","journal-title":"Cytotherapy"},{"key":"key20180107181118_b52-ijo-42-02-0419","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1158\/1078-0432.CCR-07-2223","article-title":"The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance","volume":"14","author":"Meads","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2012.1729\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T17:13:22Z","timestamp":1643822002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2012.1729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,6]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,12,6]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/ijo.2012.1729"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2012.1729","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,6]]}}}